Quick Answer
Fulgent Genetics, Inc. reported Research And Development Expense of $53.91 million for the year ending 2025.
- Fulgent Genetics, Inc. showed an increase of +10.4% in Research And Development Expense from 2024 to 2025.
- This data is from Fulgent Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Fulgent Genetics, Inc.'s Research And Development Expense has grown by 10,246.4%.
- Historical annual values: Fiscal year 2025: $53.91 million | Fiscal year 2024: $48.82 million | Fiscal year 2023: $41.44 million | Fiscal year 2022: $28.91 million | Fiscal year 2021: $24.22 million | Fiscal year 2020: $11.58 million | Fiscal year 2019: $6.54 million | Fiscal year 2018: $5.53 million | Fiscal year 2017: $4.22 million | Fiscal year 2016: $3.56 million | Fiscal year 2015: $4.43 million | Fiscal year 2014: $521.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: